Millennium Management
SNOA icon

Millennium Management’s Sonoma Pharmaceuticals SNOA Stock Holding History

Millennium Management’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-651
Closed -$2.17K – 6485
2024
Q1 		$2.17K Sell
651
-944
-59% -$3.05K ﹤0.01% 6062
2023
Q4 		$5.75K Buy
+1,595
New +$10.2K ﹤0.01% 5803
2023
Q2 		– Sell
-1,179
Closed -$23K – 6647
2023
Q1 		$23K Buy
1,179
+349
+42% +$9K ﹤0.01% 5834
2022
Q4 		$19K Buy
+830
New +$29.5K ﹤0.01% 6066
2014
Q2 		– Sell
-13
Closed -$43K – 3825
2014
Q1 		$43K Buy
+13
New +$44.2K ﹤0.01% 3362

Other funds holding SNOA

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Millennium Management's SNOA Position: Q2 2024 in Review

Millennium Management sold out of Sonoma Pharmaceuticals (SNOA) in Q2 2024, closing a stake of 651 shares — an estimated $2.17K sold.

Millennium Management first reported a position in SNOA in Q1 2014 and held it in 5 quarters. The position peaked at $43K in Q1 2014. 17 funds tracked by Wall St. Rank hold SNOA as of Q2 2024.

  • Millennium Management reported no remaining Sonoma Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Millennium Management sold 651 Sonoma Pharmaceuticals shares in Q2 2024, an estimated $2.17K.
  • Millennium Management first reported a position in Sonoma Pharmaceuticals in Q1 2014 and held it in 5 quarters.
  • Millennium Management's Sonoma Pharmaceuticals position peaked at $43K in Q1 2014.
  • 17 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q2 2024.

Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.